Evaluating No Preconditioning Approaches in Autoimmune Therapies

2:00 pm - Wednesday 2nd December 2026

  • Reviewing emerging no preconditioning data in PV to assess its impact on treatment strategies and patient burden
  • Incorporating potential updates from lupus studies to provide a broader perspective on applicability across indications
  • Assessing how removing preconditioning could reshape clinical adoption and plenary-level discussion within the field

Speakers:

Associate Director, Translational Medicine
Cabaletta Bio